Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$1.71 - $3.61 $106,461 - $224,751
62,258 New
62,258 $116,000
Q2 2021

Aug 13, 2021

BUY
$26.09 - $40.4 $5.73 Million - $8.87 Million
219,465 New
219,465 $7.4 Million
Q1 2020

Apr 09, 2020

SELL
$7.64 - $27.5 $101,749 - $366,245
-13,318 Closed
0 $0
Q4 2019

Jan 16, 2020

BUY
$15.02 - $20.57 $200,036 - $273,951
13,318 New
13,318 $215,000

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Alpine Global Management, LLC Portfolio

Follow Alpine Global Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpine Global Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpine Global Management, LLC with notifications on news.